Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:04 PM
Ignite Modification Date:
2025-12-24 @ 10:04 PM
NCT ID:
NCT02061735
Eligibility Criteria:
Inclusion Criteria:
* Age ≤ 5 years of age
* Diagnosis of a cutaneous infantile hemangioma
* Diagnosis of hemangioma requiring treatment (treatment includes: propranolol or topical timolol) or diagnosis of an infantile hemangioma that will not be treated at the time of enrollment
* Able to tolerate imaging procedures
Exclusion Criteria:
* Age \> 5 years
* Non cutaneous infantile hemangioma
* Hemangioma on the lip
* Hemangioma on the eyelid
* Hemangioma located in areas whereby measurements cannot be made due to equipment limitations
* Deep hemangioma with no visible skin surface component
* Congenital hemangioma
* No available normal site for study control
* Other vascular anomaly
* Not able to tolerate imaging procedures
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
1 Month
Maximum Age:
5 Years
Study:
NCT02061735
Study Brief:
Protocol Section:
NCT02061735